These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 21706917)
1. Multidrug resistance-associated biomarkers PGP, GST-pi, Topo-II and LRP as prognostic factors in primary ovarian carcinoma. Lu D; Shi HC; Wang ZX; Gu XW; Zeng YJ Br J Biomed Sci; 2011; 68(2):69-74. PubMed ID: 21706917 [TBL] [Abstract][Full Text] [Related]
2. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954 [TBL] [Abstract][Full Text] [Related]
3. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336 [TBL] [Abstract][Full Text] [Related]
4. [Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma]. Yu DQ; Yi YF Ai Zheng; 2003 May; 22(5):496-9. PubMed ID: 12753710 [TBL] [Abstract][Full Text] [Related]
5. [Expression and implication of Pgp, MRP, LRP, GST-pi, Topo II alpha in tongue squamous cell carcinoma]. Leng WD; Wang DZ; Feng G; He J Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Feb; 22(1):23-5. PubMed ID: 15017692 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of the resistance proteins LRP, Pgp, MRP1, MRP3, and MRP5 in epithelial ovarian cancer. Sedláková I; Laco J; Caltová K; Červinka M; Tošner J; Řezáč A; Špaček J Int J Gynecol Cancer; 2015 Feb; 25(2):236-43. PubMed ID: 25594141 [TBL] [Abstract][Full Text] [Related]
7. [The expression of MRP, GST-pi, Topo IIalpha and COX-2 in epithelial ovarian cancer and its relationship to drug resistance and prognosis]. Cao DY; Shen K; Yang JX; Guan J Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1738-41. PubMed ID: 17919376 [TBL] [Abstract][Full Text] [Related]
8. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. Izquierdo MA; van der Zee AG; Vermorken JB; van der Valk P; Beliën JA; Giaccone G; Scheffer GL; Flens MJ; Pinedo HM; Kenemans P J Natl Cancer Inst; 1995 Aug; 87(16):1230-7. PubMed ID: 7563169 [TBL] [Abstract][Full Text] [Related]
9. The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer. Geng M; Wang L; Chen X; Cao R; Li P Diagn Pathol; 2013 Dec; 8():198. PubMed ID: 24326092 [TBL] [Abstract][Full Text] [Related]
10. [Drug resistance proteins LRP, Pgp, MRP1, MRP3 and MRP5 in ovarian cancer patients]. Sedláková I; Laco J; Tošner J; Spaček J; Cermáková E Ceska Gynekol; 2013 Dec; 78(6):545-53. PubMed ID: 24372433 [TBL] [Abstract][Full Text] [Related]
11. Lung resistance-related protein (LRP) expression in malignant ascitic cells as a prognostic marker for advanced ovarian serous carcinoma. Kerr EH; Frederick PJ; Egger ME; Stockard CR; Sellers J; DellaManna D; Oelschlager DK; Amm HM; Eltoum IE; Straughn JM; Buchsbaum DJ; Grizzle WE; McNally LR Ann Surg Oncol; 2013 Sep; 20(9):3059-65. PubMed ID: 23525731 [TBL] [Abstract][Full Text] [Related]
12. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells. Kim WJ; Kakehi Y; Yoshida O Int J Urol; 1997 Nov; 4(6):583-90. PubMed ID: 9477189 [TBL] [Abstract][Full Text] [Related]
13. [Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma]. Katsaros D; Fracchioli S; Arts HJ; de Vries EG; Danese S; Richiardi G; Arisio R; Gordini G; Van der Zee AG; Suurmeijer AJ; Massobrio M Minerva Ginecol; 1999 Dec; 51(12):463-70. PubMed ID: 10767994 [TBL] [Abstract][Full Text] [Related]
14. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas. Volm M; Kästel M; Mattern J; Efferth T Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529 [TBL] [Abstract][Full Text] [Related]
15. Expression of multidrug resistance-associated proteins and their relation to postoperative individualized chemotherapy in gastric cancer. Yu P; Du Y; Cheng X; Yu Q; Huang L; Dong R World J Surg Oncol; 2014 Oct; 12():307. PubMed ID: 25304659 [TBL] [Abstract][Full Text] [Related]
16. [Proteins of resistance and drug resistance in ovarian carcinoma patients]. Sedláková I; Laco J; Tošner J; Caltová K; Cervinka M; Rezáč A; Spaček J; Skapinec P Klin Onkol; 2012; 25(6):457-63. PubMed ID: 23301649 [TBL] [Abstract][Full Text] [Related]
17. Synovial sarcoma: immunohistochemical expression of P-glycoprotein and glutathione S transferase-pi and clinical drug resistance. Lopes JM; Bruland OS; Bjerkehagen B; Silva MC; Holm R; Pettersen EO; Solheim OP; Sobrinho-Simões M; Nesland JM Pathol Res Pract; 1997; 193(1):21-36. PubMed ID: 9112270 [TBL] [Abstract][Full Text] [Related]
18. Significance of multidrug resistance gene-related proteins in the postoperative chemotherapy of gastric cancer. Yu P; Du Y; Yang L; Fan S; Wu J; Zheng S Int J Clin Exp Pathol; 2014; 7(11):7945-50. PubMed ID: 25550836 [TBL] [Abstract][Full Text] [Related]
19. Co-expression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42. Moran E; Cleary I; Larkin AM; Amhlaoibh RN; Masterson A; Scheper RJ; Izquierdo MA; Center M; O'Sullivan F; Clynes M Eur J Cancer; 1997 Apr; 33(4):652-60. PubMed ID: 9274450 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of lung-resistance protein and increased P-glycoprotein function in acute myeloid leukaemia cells predict a poor response to chemotherapy and reduced patient survival. Borg AG; Burgess R; Green LM; Scheper RJ; Yin JA Br J Haematol; 1998 Dec; 103(4):1083-91. PubMed ID: 9886324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]